• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国银屑病患者的心血管合并症:一项全国范围内基于登记的研究。

Cardiovascular comorbidities among patients with psoriasis: a national register-based study in China.

机构信息

School of Public Health, Jining Medical University, Jining, 272067, Shandong, China.

Department of Dermatology, Jining No.1 People's Hospital, Jining, 272067, Shandong, China.

出版信息

Sci Rep. 2024 Aug 24;14(1):19683. doi: 10.1038/s41598-024-70707-w.

DOI:10.1038/s41598-024-70707-w
PMID:39181937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11344856/
Abstract

This study aims to illustrate epidemiology of comorbid CVD in the real-world clinical setting of patients with psoriasis in China. We used data of adult patients with psoriasis who were registered in the register of China National Clinical Center for Skin and Immune Diseases between August 2020 and September 2021. Psoriasis was clinically diagnosed following the national guidelines. Univariate and multivariate logistic regression models were used to examine the factors associated with comorbid CVD in patients with psoriasis. Of the 11,560 psoriasis patients (age ≥ 18 years, mean age 41.87 years, 64.88% males), 236 were ascertained with CVD, with the overall prevalence being 2.62%. Multivariate logistic regression analysis suggested that the odds ratio (95% confidence interval) of CVD in psoriasis patients was 2.27 (2.03-2.54) for older age (per 10-year increment), 0.65 (0.48-0.90) for female, 2.07 (1.39-3.06) for obesity (BMI ≥ 28 vs. < 24 kg/m), 2.55 (1.85-2.52) for smoking, 7.63 (5.86-9.94) for hypertension, 4.27 (3.76-4.85) for diabetes, 1.14 (1.00-1.30) for having a history of drug allergy, 2.27 (1.61-3.20) for having family history of psoriasis, and 1.76 (1.16-2.67) for severe disease (severe vs. mild) with a dose-response relationship (P < 0.001). In patients with psoriasis, comorbid CVD was associated with smoking, obesity, hypertension, diabetes, history of drug allergy, family history of psoriasis, and the psoriasis severity.

摘要

本研究旨在阐明中国真实临床环境中银屑病患者合并 CVD 的流行病学情况。我们使用了 2020 年 8 月至 2021 年 9 月期间在中国国家皮肤与免疫疾病临床医学研究中心注册的成年银屑病患者的数据。银屑病的临床诊断符合国家指南。采用单因素和多因素 logistic 回归模型来检验银屑病患者合并 CVD 的相关因素。在 11560 例(年龄≥18 岁,平均年龄 41.87 岁,64.88%为男性)银屑病患者中,有 236 例患者被确诊为 CVD,总体患病率为 2.62%。多因素 logistic 回归分析表明,银屑病患者 CVD 的优势比(95%置信区间)为:年龄每增加 10 岁(2.27[2.03-2.54])、女性(0.65[0.48-0.90])、肥胖(BMI≥28 与<24 kg/m2)(2.07[1.39-3.06])、吸烟(2.55[1.85-2.52])、高血压(7.63[5.86-9.94])、糖尿病(4.27[3.76-4.85])、药物过敏史(1.14[1.00-1.30])、银屑病家族史(2.27[1.61-3.20])和严重疾病(重度与轻度)(1.76[1.16-2.67])与剂量反应关系(P<0.001)。在银屑病患者中,合并 CVD 与吸烟、肥胖、高血压、糖尿病、药物过敏史、银屑病家族史和疾病严重程度相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf86/11344856/871b886a3ce5/41598_2024_70707_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf86/11344856/b3a173936d91/41598_2024_70707_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf86/11344856/6efbe6273c9f/41598_2024_70707_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf86/11344856/871b886a3ce5/41598_2024_70707_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf86/11344856/b3a173936d91/41598_2024_70707_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf86/11344856/6efbe6273c9f/41598_2024_70707_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf86/11344856/871b886a3ce5/41598_2024_70707_Fig3_HTML.jpg

相似文献

1
Cardiovascular comorbidities among patients with psoriasis: a national register-based study in China.中国银屑病患者的心血管合并症:一项全国范围内基于登记的研究。
Sci Rep. 2024 Aug 24;14(1):19683. doi: 10.1038/s41598-024-70707-w.
2
Prevalence of Metabolic Syndrome in Chinese Patients With Erythrodermic Psoriasis: A Case-Control Study.红皮病型银屑病患者代谢综合征的患病率:一项病例对照研究。
Front Endocrinol (Lausanne). 2021 Dec 14;12:677912. doi: 10.3389/fendo.2021.677912. eCollection 2021.
3
High prevalence of cardiovascular risk factors in patients with moderate or severe psoriasis in northern China.中国北方中重度银屑病患者心血管危险因素高发。
Arch Dermatol Res. 2014 Apr;306(3):247-51. doi: 10.1007/s00403-013-1437-3. Epub 2014 Jan 3.
4
Prevalence of cardiovascular risk factors in patients with psoriasis.银屑病患者心血管危险因素的患病率。
J Am Acad Dermatol. 2006 Nov;55(5):829-35. doi: 10.1016/j.jaad.2006.08.040. Epub 2006 Sep 25.
5
Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study.基层医疗中强直性脊柱炎、银屑病关节炎和银屑病患者心血管相关合并症的患病率:一项配对回顾性队列研究
Clin Rheumatol. 2016 Dec;35(12):3069-3073. doi: 10.1007/s10067-016-3362-2. Epub 2016 Aug 2.
6
Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases.法国银屑病患者的代谢合并症和高血压。与法国国家数据库的比较。
Ann Dermatol Venereol. 2016 Apr;143(4):264-74. doi: 10.1016/j.annder.2015.06.024. Epub 2016 Mar 8.
7
Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis.银屑病与心血管危险因素:一项住院患者病例对照研究,比较银屑病与皮炎。
J Am Acad Dermatol. 2012 Feb;66(2):252-8. doi: 10.1016/j.jaad.2010.11.046. Epub 2011 Jul 13.
8
Dyslipidemia and its associated factors among community adults located in Shangcheng district, Zhejiang province.浙江省尚城区社区成年人血脂异常及其相关因素。
Sci Rep. 2024 Feb 21;14(1):4268. doi: 10.1038/s41598-024-54953-6.
9
Comorbidities and cardiovascular risk factors in patients with psoriasis.银屑病患者的合并症及心血管危险因素
An Bras Dermatol. 2014 Sep-Oct;89(5):735-44. doi: 10.1590/abd1806-4841.20142874.
10
Family history predicts major adverse cardiovascular events (MACE) in young adults with psoriasis.家族史可预测年轻银屑病患者的主要不良心血管事件(MACE)。
J Am Acad Dermatol. 2016 Aug;75(2):340-6. doi: 10.1016/j.jaad.2016.02.1227. Epub 2016 Jun 7.

引用本文的文献

1
Diabetes is associated with a poor prognosis in patients with psoriasis and coronary artery disease.糖尿病与银屑病和冠状动脉疾病患者的不良预后相关。
BMC Endocr Disord. 2025 Jul 14;25(1):174. doi: 10.1186/s12902-025-01996-z.
2
Psoriasis and Seasonality: Exploring the Genetic and Epigenetic Interactions.银屑病与季节性:探索遗传与表观遗传的相互作用。
Int J Mol Sci. 2024 Oct 30;25(21):11670. doi: 10.3390/ijms252111670.

本文引用的文献

1
Cardiovascular comorbidity in psoriasis - psoriatic inflammation is more than just skin deep.银屑病的心血管共病 - 银屑病炎症不只是皮肤问题。
J Dtsch Dermatol Ges. 2023 Jul;21(7):718-725. doi: 10.1111/ddg.15071. Epub 2023 Apr 26.
2
Effects of Biologic Therapy on Laboratory Indicators of Cardiometabolic Diseases in Patients with Psoriasis.生物疗法对银屑病患者心脏代谢疾病实验室指标的影响。
J Clin Med. 2023 Mar 1;12(5):1934. doi: 10.3390/jcm12051934.
3
Psoriasis and cardiovascular disease risk in European and East Asian populations: evidence from meta-analysis and Mendelian randomization analysis.
银屑病与欧洲及东亚人群心血管疾病风险:来自荟萃分析和孟德尔随机化分析的证据。
BMC Med. 2022 Nov 1;20(1):421. doi: 10.1186/s12916-022-02617-5.
4
Prevalence of cardiovascular risk factors in patients with psoriasis.银屑病患者心血管危险因素的流行情况。
Cent Eur J Public Health. 2022 Jun;30(Supplement):S05-S10. doi: 10.21101/cejph.a6806.
5
Estrogen Receptor and Vascular Aging.雌激素受体与血管衰老
Front Aging. 2021 Sep 24;2:727380. doi: 10.3389/fragi.2021.727380. eCollection 2021.
6
The impact of gender and sex in psoriasis: What to be aware of when treating women with psoriasis.性别和性在银屑病中的影响:治疗银屑病女性患者时需注意的事项。
Int J Womens Dermatol. 2022 Apr 13;8(2):e010. doi: 10.1097/JW9.0000000000000010. eCollection 2022 Jun.
7
Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis.银屑病与代谢综合征:对银屑病治疗与管理的启示。
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):797-806. doi: 10.1111/jdv.18044. Epub 2022 Mar 14.
8
Psoriasis and coronary heart disease-not as severe as predicted.银屑病与冠心病——并不像预测的那么严重。
QJM. 2022 Jun 7;115(6):388-392. doi: 10.1093/qjmed/hcab173.
9
Prevalence and severity of coronary artery disease linked to prognosis in psoriasis and psoriatic arthritis patients: a multi-centre cohort study.银屑病和银屑病关节炎患者的冠状动脉疾病患病率和严重程度与预后相关:一项多中心队列研究。
J Intern Med. 2021 Sep;290(3):693-703. doi: 10.1111/joim.13311. Epub 2021 Jun 3.
10
Psoriasis.银屑病。
Lancet. 2021 Apr 3;397(10281):1301-1315. doi: 10.1016/S0140-6736(20)32549-6.